Dr. Deborah Jo Levine, MD

Dr. Levine practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Levine's NPI, 1831206804, was assigned on August 24, 2006. Dr. Levine graduated from College of Medicine - Tucson in 1996. Dr. Levine holds California license C181690.

Dr. Levine's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Levine's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. Dr. Levine is also affiliated with University Hospital. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Levine to 1 more hospital and 1 medical group, each named with a free account. Dr. Levine's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Levine practices, 3 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Levine's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Levine is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Levine's licenses on file in 3 states: California, Arizona and Texas.

Dmand AI lists chronic lung disease among the conditions Dr. Levine treats.

CMS data shows 855 Medicare services from Dr. Levine across 6 procedure codes in 2024, for 138 Medicare patients. Medicare paid $109,699 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 138 Medicare patients who saw Dr. Levine in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 4.37, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Levine's median patient age at 61, with 45% women.

In 2024, Dr. Levine wrote 1,335 Medicare Part D claims for 152 patients. 87% of them were for generic drugs. CMS names the drug for 1,096 of them, across 32 drugs with 11 or more claims each, at $423,364 in total drug cost. In 2023, CMS named 440 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Levine for performance year 2024, reported as part of a group. Dr. Levine accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 36 papers to Dr. Levine, published from 2009 to 2025. 2023 was the busiest year, with 7. The most frequent topics are Lung Transplantation, Graft Rejection and Lung. Dr. Levine has published most often in J Heart Lung Transplant. Dr. Levine's most frequent co-authors are Gerald J. Berry, MD, Irina Liliana Timofte, MD and Sean Agbor-Enoh, MD, PhD.

CMS Open Payments shows 275 general payments to Dr. Levine from 20 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 36% of the total. Insmed, Inc. paid the most, $78,479.

Dr. Levine graduated from College of Medicine - Tucson in 1996.

Dr. Levine is in network with 18 carriers, including Aetna, Elevance and United Healthcare. HMO plans come from the most carriers, 11. Check the plan with the practice before a visit.